Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Noncontrolling Interest [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Preferred Stock [Member] The 2022 Private Placement [Member]	Preferred Stock [Member] Multi-Tranche Private Placement 2023 [Member]	Preferred Stock [Member] The 2023 Series X Private Placement [Member]	[1]	Common Stock [Member]		Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2022						3,185,000	0	0		5,161,374
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022	$ 0	$ 0	$ (548)	$ 0	$ (548)
Balance at Dec. 31, 2022										$ 29		$ 232,169	$ (224,105)	$ 645	$ 8,738
Issuance of common stock (in shares)						0	0	0		224,378
Issuance of common stock										$ 1		744	0	0	745
Net loss — the Company										0		0	(9,657)	0	(9,657)
Net income attributable to non-controlling interest										0		0	0	34	34
Stock-based compensation										$ 0		481	0	0	481
Restricted share units vested (in shares)						0	0	0		22,000
Restricted share units vested										$ 0	[1]	0	0	0	0
Balance (in shares) at Mar. 31, 2023						3,185,000	0	0		5,407,752
Balance at Mar. 31, 2023										$ 30		233,394	(234,310)	679	(207)
Balance (in shares) at Dec. 31, 2023						3,185,000	1,575,810	256,356		5,529,149
Balance at Dec. 31, 2023										$ 30		247,854	(261,903)	570	(13,449)
Issuance of common stock (in shares)						0	0	0		8,333
Issuance of common stock										$ 0	[1]	10	0	0	10
2024 Registered Direct Offering shares and warrants, net of costs (in shares)						0	0	0		817,748
2024 Registered Direct Offering shares and warrants, net of costs										$ 0		977	0	0	977
2023 Series X Private Placement shares dividends (in shares)						0	0	8,012		0
2023 Series X Private Placement shares dividends										$ 0		0	0	0	0
Net loss — the Company										0		0	(9,794)	0	(9,794)
Net income attributable to non-controlling interest										0		0	0	5	5
Stock-based compensation										$ 0		339	0	0	339
Balance (in shares) at Mar. 31, 2024						3,185,000	1,575,810	264,368		6,355,230
Balance at Mar. 31, 2024										$ 30		$ 249,180	$ (271,697)	$ 575	$ (21,912)

[1] Presented as $0 due to rounding.